How to use the speech recognition tool?

TESOLAUK - NCT01847365

TES for the Treatment of Retinitis Pigmentosa (RP)

TES for the Treatment of Retinitis Pigmentosa (RP).

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2013-04-01
  • Closing Date: 2015-02-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: